Composition comprising a sustained release coating or matrix and an NMDA receptor antagonist, method for administration such NMDA antagonist to a subject

Details for Australian Patent Application No. 2005309601 (hide)

Owner Neuromolecular Pharmaceuticals, Inc.

Inventors Burkoth, Timothy; Porter, Seth; Fultz, Timothy J.; Meyerson, Laurence R.; Went, Gregory T.

Agent Spruson & Ferguson

Pub. Number AU-A-2005309601

PCT Pub. Number WO2006/058059

Priority 11/048,002 31.01.05 US; 11/058,118 14.02.05 US; 60/635,786 13.12.04 US; 60/635,365 10.12.04 US; 11/058,141 14.02.05 US; 60/630,885 23.11.04 US; 60/701,857 22.07.05 US

Filing date 22 November 2005

Wipo publication date 1 June 2006

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 9/52 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/058059 Priority application(s): WO2006/058059

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309605-2,3,4-substituted-cyclopentanones as therapeutic agents

2005309599-Composite mixer